Nothing Special   »   [go: up one dir, main page]

Leddy et al., 1977 - Google Patents

Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera

Leddy et al., 1977

View PDF
Document ID
7870317180478154986
Author
Leddy J
Simons R
Douglas R
Publication year
Publication venue
The Journal of Immunology

External Links

Snippet

The capacity of human sera genetically deficient in selective complement (C) components to enhance neutralization of enveloped viruses was examined by kinetic plaque reduction assays. Vaccinia virus, a DNA virus, and vesicular stomatitis virus (VSV), an RNA virus, were …
Continue reading at scholar.archive.org (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Similar Documents

Publication Publication Date Title
Leddy et al. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera
Perrin et al. Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F (ab') 2, and the alternative complement pathway.
Mitra et al. Elimination of infectious retroviruses during preparation of immunoglobulins
ES2476416T3 (en) Composition of intravenous immunoglobulin
Rotbart et al. Persistent enterovirus infection in culture-negative meningoencephalitis: demonstration by enzymatic RNA amplification
Garcia-Fuentes et al. Cryoglobulinaemia in Henoch-Schönlein purpura.
Laiwah et al. Lymphocyte transforamtion and leucocyte migration–inhibition by Australia antigen
Snyder Jr et al. Specificities of human immunoglobulins reactive with antigens in preparations of several mammalian type-C viruses
Hart et al. Effect of terminal (dry) heat treatment on non-enveloped viruses in coagulation factor concentrates
Schmidt et al. Characterization of antibodies produced in natural and experimental coxsackievirus infections
Miller et al. Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines
Tedesco et al. A familial dysfunction of the eighth component of complement (C8)
JP2537850B2 (en) Manufacturing method of immunoglobulin without retrovirus
JPH06509866A (en) Method of screening plasma samples for effective antibody titers against respiratory viruses
Mills et al. Antibody-independent neutralization of vesicular stomatitis virus by human complement: I. Complement requirements
Garcia-Tapia et al. Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain
Gard et al. Hemagglutination by Col-MM-virus
Weller Varicella—Herpes Zoster Virus
TINDALL et al. Serum antibodies to cytomegalovirus in myasthenia gravis: effects of thymectomy and steroids
Zaia et al. A practical method for preparation of varicella-zoster immune globulin
Sköldenberg et al. Transient appearance of oligoclonal immunoglobulins and measles virus antibodies in the cerebrospinal fluid in a case of acute measles encephalitis.
FISCUS et al. Infectious immune complexes in HIV-1-infected patients
Pincus et al. Reactivities of systemic lupus erythematosus sera with cellular and virus antigen preparations
Sallay et al. Immunofluorescent studies on circulating lymphocytes in oral mucosal diseases
Collins et al. Normal chicken cells (chf−) express a surface antigen which cross-reacts with determinants of the major envelope glycoprotein (gp85) of avian myeloblastosis virus